Many orthopedic surgeons have the income to build generational wealth, but not the structure to capture it. This article breaks down the “raccoon trap” of lifestyle inflation, shows how small shifts in spending and saving create six‑figure differences over a decade, and explains how tools like cash balance plans and intentional S‑Corp design can redirect more of your income toward long‑term freedom instead of the parking lot.

Open enrollment isn’t just a benefits paperwork exercise — it’s a tax planning opportunity. For orthopedic surgeons and other high-income physicians, the way you structure your health insurance, HSA, healthcare FSA, and dependent care FSA elections can materially impact your tax bill and long-term wealth. This article breaks down the 2026 limits, HDHP eligibility rules, and practical strategies to optimize your benefits before you lock in elections for the year.

Orthopedic surgeons rarely realize how much practice value is created long before a buyer shows up.

This article breaks down a three‑year succession runway designed for independent orthopedic practices: Year 3 focuses on systemization and personal goodwill documentation, Year 2 on associate hiring and referral mapping, and Year 1 on buyer engagement, deal structure, and tax planning.

You’ll see how hospital productivity benchmarks, surgeon‑dependent revenue, ASC equity, and properly documented personal goodwill can change EBITDA multiples and after‑tax proceeds by seven figures at exit.

Most surgeons start year-end tax planning too late—and leave tens of thousands of dollars on the table. This article outlines a five-month protocol for surgeon practice owners, detailing how donor-advised funds, equipment purchases under Section 179, retirement plan amendments, Roth conversions, and installment sale planning must be sequenced from July through December to maximize 2026 tax savings.

Independent orthopedic practices used to set the productivity standard. That dynamic has flipped—hospital-employed surgeons now lead on work RVUs, and sophisticated buyers are using those benchmarks to model lower post-sale revenue in private practices. In this article, we walk through how normalized EBITDA, RVU assumptions, and hospital infrastructure advantages are changing what your practice is worth, and outline three concrete steps to protect—and potentially increase—your exit value.

A cash balance plan can be one of the most powerful tax‑deferred tools available to a practice‑owning surgeon—but only if it’s funded on schedule. This article walks you through a simple mid‑year pacing check, explains what chronic underfunding can cost in taxes and penalties, and shows how to coordinate your cash balance plan with your 401(k) and profit‑sharing strategy so you stay within IRS limits and keep your largest tax shelter on track.

The first half of the year is already written. For surgeons who own their practice, that makes midyear the most underused planning window on the calendar. In one Saturday, you can run a simple “halftime report” on five numbers—income, tax liability pacing, retirement contribution progress, practice overhead, and personal spending rate—and make small adjustments while they’re still cheap. This framework helps surgeon‑owners avoid fourth‑quarter scrambles, smooth cash flow, and turn more of a surgeon‑level income into lasting wealth.

Many surgeons reflexively defer income every year, assuming next year’s tax bill will somehow be lower. This post breaks down when income deferral genuinely saves tax—and when it quietly backfires—by looking at real‑world scenarios like gap years, practice sales, and state moves. Use it to ask sharper questions with your advisor before the calendar locks in your 2026 tax outcome.

Interest rate headlines change every month. Your financial structure shouldn’t. This article shows orthopedic surgeons how to build an if‑then framework for cash, practice debt, and portfolios, so FOMC week becomes a simple review point—not a trigger for rushed, reactive decisions.

June looks quiet on the calendar, but it is one of the most important months for surgeon practice owners to reassess taxes and cash flow. In about 30 minutes, you can review income pacing, estimated payments, retirement plan funding, and household liquidity before the June 15 deadline. That midyear “audit” turns vague concern into one clear decision, so the rest of 2026 feels planned instead of reactive.

Orthopedic surgeons spend months obsessing over valuations, deal terms, and tax strategies—then face a harder question once the wire hits: what now? This article walks through the identity gap no one warns you about, how to design a purposeful “second act,” and the financial guardrails that can protect your practice-sale proceeds from lifestyle creep and impulsive decisions. If you are planning to sell to private equity or another buyer, this is the work to do before the deal closes.

Most orthopedic surgeons look at tax returns and assume that number is what their practice is worth. In reality, buyers use normalized EBITDA—adjusted for owner pay, personal expenses, and one-time costs—to decide what they’ll actually pay. This article shows how to estimate normalized EBITDA and use it to negotiate from a position of strength.

When you sell your orthopedic practice, the IRS cares how much of the price is the business—and how much is you. This article explains personal vs. enterprise goodwill, why early documentation matters, and how thoughtful planning can translate into six‑figure tax savings at exit.

Private equity offers orthopedic surgeons big multiples and polished pitch decks—but the real story lives in the fine print. This article walks through how rollover equity, compensation resets, EBITDA ‘engineering,’ and PE hold periods actually work in many orthopedic deals. It then shows, with a simple $4M practice sale example, how planning around personal goodwill and deal structure can change a surgeon’s federal tax bill by hundreds of thousands of dollars. If you’re an orthopedic surgeon being courted by private equity, this is the pre‑dinner framework to read before you say yes—or no.

Most surgeons wait until 12–18 months before retirement to think about selling their practice—by then, leverage and tax options are already limited. This article lays out a five‑year, physician‑specific exit protocol that helps you separate personal goodwill, diversify revenue, recruit an associate, and structure a sale that supports both your valuation and after‑tax proceeds.

Most surgeons get second opinions in the OR, not in their financial lives. This article shows how a coordinated review of entity structure, retirement plan design, tax strategy, and investments can uncover six‑figure opportunities hiding between your CPA, advisor, and attorney.

Most surgeons move on after filing taxes, but the months between April 15 and year-end can be the most important planning window of the year. This article explains four high-impact moves—S-Corp salary review, cash balance plan setup, entity structure evaluation, and Roth conversion analysis—and why acting earlier creates more options

For years, “just do the backdoor Roth” was default advice for high‑earning surgeons. But after 2025’s OBBBA changes, that rule of thumb can quietly cost you money. This article walks through a simple three‑branch framework to decide when Roth still wins, when traditional and cash balance contributions create more value, and how your state‑to‑state tax trajectory can flip the answer. Before you fund another backdoor Roth on autopilot, model both paths and let the math—not the calendar—drive the decision.

Most surgeons never read their tax return the way they read an MRI. This article shows you four diagnostic markers—effective tax rate, QBI, retirement funding, and state tax—that reveal whether your financial structure is working or leaking.

Most surgeons track collections, not what they actually keep per clinical hour. In this article, I walk through a real‑world style example of a 2.4M orthopedic practice and show how overhead, tax structure, retirement plan design, and debt service combine to create a much lower effective hourly rate than most surgeons expect—and how targeted structural changes can raise that rate without adding a single additional case.